Although many studies have found psychological depression associated with higher circulating levels of C-reactive protein (CRP), not all findings are consistent. Since DNA sequence variation in the CRP gene has also been shown to predict plasma CRP levels, we hypothesized that plasma CRP may covary with depressive symptomatology as a function of allelic variation in the CRP gene. We tested this hypothesis in 868 healthy community volunteers of European ancestry. Depressive symptomatology was measured using the Center for Epidemiological Studies-Depression (CESD) scale, and plasma CRP was assayed from whole blood. Three polymorphisms [rs1417938 (A/T), rs1800947 (C/G) and rs1205 (C/T)] were genotyped and three-locus haplotypes were generated. Regression models adjusting for demographic and lifestylerelated covariates showed no direct association of CESD depression scores with CRP. In regression models adjusting for age, gender, education, smoking status and statin use, one CRP haplotype (T-G-C) was associated with CRP level (p = 0.014) and a second haplotype (A-G-T) showed marginal association (p = 0.064, respectively). Neither haplotype was related to depressive symptoms. However, plasma CRP was predicted by the interaction of A-G-T haplotype with depressive symptomatology (p = 0.009). Higher CESD scores were associated positively with CRP levels among individuals with the A-G-T haplotype (p = 0.004). In secondary analyses, body mass index was found to partially account for the moderating effects of the A-G-T haplotype on the association of depression with circulating CRP. In conclusion, we found that haplotypic variation in the CRP locus moderates an association of depressive symptoms with circulating CRP, which is partially mediated by BMI.
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Introduction
C-reactive protein (CRP) is a circulating marker of systemic inflammation that has been shown to predict cardiovascular pathology and mortality in epidemiological investigations (Ridker et al., 2006; Ridker and Cook, 2007; Sabatine et al., 2007) . A growing literature suggests that clinical depression and self-reported depressive symptomatology covary positively with circulating CRP levels, even after adjusting for traditional risk factors, including age, sex, race, smoking status, body mass index (BMI) and HDL cholesterol concentrations (Danner et al., 2003; Ford and Erlinger, 2004; Penninx et al., 2003; Kop et al., 2002) . However, other studies have either failed to observe an association between depression and circulating CRP (Bremmer et al., 2008; Hemingway et al., 2003; Janszky et al., 2005; Ladwig et al., 2003; Schins et al., 2005) or have observed an inverse relationship (Whooley et al., 2007) . These inconsistencies may stem from differences in study sample (patient vs. community-based samples), index of depression (clinical diagnosis or symptom report), or other differences of methodology or analysis (e.g. range of covariate adjustments). It is also possible that unexamined genetic factors moderate associations between affect and CRP.
Biometric studies show genetic variation to account for a significant portion of interindividual variability in circulating levels of CRP, with estimated heritability of about 0.4 (Pankow et al., 2001; Vickers et al., 2002) . Additionally, DNA sequence variation in the gene encoding CRP (the CRP gene) has been associated with levels of circulating CRP (Carlson et al., 2005; Crawford et al., 2006; Kathiresan et al., 2006; Lange et al., 2006; Miller et al., 2005; Russell et al., 2004; Szalai et al., 2005; Wang et al., 2006) . Moreover, one recent study has shown that common genetic variation
